Dose-Finding Study to Evaluate the Safety, Efficacy, & Tolerability of Multiple Doses of rAvPAL-PEG in Subjects With PKU
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether weekly injections of phenylalanine ammonia
lyase (rAvPAL-PEG) can reduce blood phenylalanine concentrations in PKU subjects and whether
repeated administration is safe.